Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

20.66
Delayed Data
As of Aug 26
 +0.03 / +0.15%
Today’s Change
19.10
Today|||52-Week Range
46.24
-52.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues183.5M193.3M190.5M186.5M
 
 
 
 
 
Cost of Goods Sold29.7M33.8M33.6M33.3M
 
 
 
 
 
Depreciation And Amortization6.8M6.8M6.6M6.7M
 
 
 
 
 
 
Operating ExpensesGross Income147.0M152.7M150.3M146.5M
 
 
 
 
 
General Expenses103.7M107.5M107.7M110.8M
 
 
 
 
 
Research And Development17.2M16.7M17.2M19.5M
 
 
 
 
 
Total Operating Expenses140.2M148.1M147.9M150.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income43.3M45.2M42.6M35.7M
 
 
 
 
 
Other Expenses100.0K-300.0K200.0K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income43.5M45.0M43.1M37.3M
 
 
 
 
 
Income Taxes-16.9M-14.7M-10.5M-13.9M
 
 
 
 
 
Net Income26.6M30.3M32.6M23.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.7M70.5M70.9M70.0M
 
 
 
 
 
Shares To Calculate EPS Diluted72.1M73.8M73.5M72.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.37$0.41$0.44$0.32
 
 
 
 
 
EPS Diluted$0.37$0.41$0.44$0.32